Citadel Advisors: Cardinal Health CAH Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 55.9 M | Compra |
251,321
+57,401
| +30% | +USD 13.3 M | 0.01% | 1452 |
|
|
2026
Q2 | USD 46.1 M | Venta |
193,920
-2,138,318
| -92% | -USD 444 M | 0.01% | 1648 |
|
|
2026
Q1 | USD 493 M | Compra |
2,332,238
+455,541
| +24% | +USD 98.1 M | 0.08% | 177 |
|
|
2025
Q4 | USD 386 M | Compra |
1,876,697
+934,750
| +99% | +USD 176 M | 0.06% | 256 |
|
|
2025
Q3 | USD 148 M | Venta |
941,947
-110,593
| -11% | -USD 17.1 M | 0.02% | 629 |
|
|
2025
Q2 | USD 177 M | Venta |
1,052,540
-1,798,782
| -63% | -USD 267 M | 0.03% | 460 |
|
|
2025
Q1 | USD 393 M | Venta |
2,851,322
-342,134
| -11% | -USD 43.6 M | 0.07% | 184 |
|
|
2024
Q4 | USD 378 M | Compra |
3,193,456
+1,530,044
| +92% | +USD 179 M | 0.07% | 210 |
|
|
2024
Q3 | USD 184 M | Compra |
1,663,412
+855,920
| +106% | +USD 89.5 M | 0.04% | 392 |
|
|
2024
Q2 | USD 79.4 M | Compra |
807,492
+540,258
| +202% | +USD 55.1 M | 0.02% | 816 |
|
|
2024
Q1 | USD 29.9 M | Venta |
267,234
-828,339
| -76% | -USD 89.4 M | 0.01% | 1666 |
|
|
2023
Q4 | USD 110 M | Compra |
1,095,573
+1,082,028
| +7,988% | +USD 107 M | 0.02% | 624 |
|
|
2023
Q3 | USD 1.18 M | Venta |
13,545
-101,116
| -88% | -USD 9.14 M | ﹤0.01% | 6237 |
|
|
2023
Q2 | USD 10.8 M | Venta |
114,661
-2,622,360
| -96% | -USD 222 M | ﹤0.01% | 2574 |
|
|
2023
Q1 | USD 207 M | Compra |
2,737,021
+2,533,450
| +1,245% | +USD 191 M | 0.05% | 310 |
|
|
2022
Q4 | USD 15.6 M | Compra |
203,571
+199,227
| +4,586% | +USD 15.1 M | ﹤0.01% | 2230 |
|
|
2022
Q3 | USD 290 k | Venta |
4,344
-1,779,107
| -100% | -USD 113 M | ﹤0.01% | 9652 |
|
|
2022
Q2 | USD 93.2 M | Compra |
1,783,451
+1,698,747
| +2,006% | +USD 96.5 M | 0.02% | 611 |
|
|
2022
Q1 | USD 4.8 M | Venta |
84,704
-475,586
| -85% | -USD 25.5 M | ﹤0.01% | 4243 |
|
|
2021
Q4 | USD 28.8 M | Compra |
560,290
+18,791
| +3% | +USD 922 k | 0.01% | 1640 |
|
|
2021
Q3 | USD 26.8 M | Compra |
541,499
+180,285
| +50% | +USD 9.8 M | 0.01% | 1670 |
|
|
2021
Q2 | USD 20.6 M | Venta |
361,214
-1,180,889
| -77% | -USD 69 M | ﹤0.01% | 2038 |
|
|
2021
Q1 | USD 93.7 M | Venta |
1,542,103
-918,293
| -37% | -USD 50.7 M | 0.02% | 614 |
|
|
2020
Q4 | USD 132 M | Venta |
2,460,396
-12,141
| -0.5% | -USD 630 k | 0.03% | 420 |
|
|
2020
Q3 | USD 116 M | Compra |
2,472,537
+1,653,384
| +202% | +USD 84.8 M | 0.03% | 389 |
|
|
2020
Q2 | USD 42.8 M | Venta |
819,153
-781,329
| -49% | -USD 40.3 M | 0.02% | 909 |
|
|
2020
Q1 | USD 76.7 M | Compra |
+1,600,482
| Nuevas | +USD 83.1 M | 0.03% | 443 |
|
|
2019
Q4 | – | Venta |
-47,473
| Cerradas | -USD 2.45 M | – | 9141 |
|
|
2019
Q3 | USD 2.24 M | Venta |
47,473
-947,009
| -95% | -USD 43.2 M | ﹤0.01% | 4302 |
|
|
2019
Q2 | USD 46.8 M | Compra |
994,482
+319,341
| +47% | +USD 14.7 M | 0.02% | 764 |
|
|
2019
Q1 | USD 32.5 M | Compra |
675,141
+237,204
| +54% | +USD 11.9 M | 0.02% | 958 |
|
|
2018
Q4 | USD 19.5 M | Compra |
437,937
+389,386
| +802% | +USD 20.3 M | 0.01% | 1257 |
|
|
2018
Q3 | USD 2.62 M | Venta |
48,551
-250,727
| -84% | -USD 12.8 M | ﹤0.01% | 3950 |
|
|
2018
Q2 | USD 14.6 M | Compra |
299,278
+77,202
| +35% | +USD 4.38 M | 0.01% | 1584 |
|
|
2018
Q1 | USD 13.9 M | Compra |
222,076
+212,011
| +2,106% | +USD 14.5 M | 0.01% | 1429 |
|
|
2017
Q4 | USD 617 k | Venta |
10,065
-184,824
| -95% | -USD 11.4 M | ﹤0.01% | 5348 |
|
|
2017
Q3 | USD 13 M | Compra |
194,889
+161,870
| +490% | +USD 11.4 M | 0.01% | 1382 |
|
|
2017
Q2 | USD 2.57 M | Venta |
33,019
-14,009
| -30% | -USD 1.06 M | ﹤0.01% | 2845 |
|
|
2017
Q1 | USD 3.84 M | Compra |
47,028
+17,644
| +60% | +USD 1.39 M | ﹤0.01% | 2312 |
|
|
2016
Q4 | USD 2.12 M | Venta |
29,384
-80,215
| -73% | -USD 5.8 M | ﹤0.01% | 2883 |
|
|
2016
Q3 | USD 8.52 M | Venta |
109,599
-28,423
| -21% | -USD 2.3 M | 0.01% | 1509 |
|
|
2016
Q2 | USD 10.8 M | Venta |
138,022
-52,978
| -28% | -USD 4.22 M | 0.01% | 1189 |
|
|
2016
Q1 | USD 15.7 M | Compra |
191,000
+35,024
| +22% | +USD 2.85 M | 0.02% | 898 |
|
|
2015
Q4 | USD 13.9 M | Compra |
155,976
+140,249
| +892% | +USD 11.9 M | 0.02% | 1051 |
|
|
2015
Q3 | USD 1.21 M | Venta |
15,727
-61,452
| -80% | -USD 5.14 M | ﹤0.01% | 3572 |
|
|
2015
Q2 | USD 6.46 M | Venta |
77,179
-945,642
| -92% | -USD 83.5 M | 0.01% | 1827 |
|
|
2015
Q1 | USD 92.3 M | Compra |
1,022,821
+227,505
| +29% | +USD 19.6 M | 0.09% | 245 |
|
|
2014
Q4 | USD 64.2 M | Compra |
795,316
+788,532
| +11,623% | +USD 62.3 M | 0.06% | 346 |
|
|
2014
Q3 | USD 508 k | Venta |
6,784
-45,869
| -87% | -USD 3.34 M | ﹤0.01% | 4593 |
|
|
2014
Q2 | USD 3.61 M | Venta |
52,653
-858,557
| -94% | -USD 58.5 M | ﹤0.01% | 2135 |
|
|
2014
Q1 | USD 63.8 M | Compra |
911,210
+740,221
| +433% | +USD 51.5 M | 0.07% | 302 |
|
|
2013
Q4 | USD 11.4 M | Venta |
170,989
-796,467
| -82% | -USD 48.7 M | 0.01% | 1125 |
|
|
2013
Q3 | USD 50.5 M | Compra |
967,456
+769,435
| +389% | +USD 39.1 M | 0.08% | 312 |
|
|
2013
Q2 | USD 9.35 M | Compra |
+198,021
| Nuevas | +USD 9.04 M | 0.02% | 1114 |
|
Otros fondos que tienen CAH en su portafolio
Posición de Citadel Advisors en CAH: resumen de T3 2026
Citadel Advisors aumentó su participación en Cardinal Health (CAH) en 30% durante T3 2026, al comprar aproximadamente USD 13.3 M y elevar la posición a 251,321 acciones con un valor de USD 55.9 M. La posición representa 0.01% del portafolio y ocupa el puesto #1452.
Citadel Advisors reportó por primera vez una posición en CAH en T2 2013 y desde entonces la ha mantenido en 53 trimestres. La posición alcanzó su máximo de USD 493 M en T1 2026. Al cierre de T3 2026, 1,490 fondos que sigue Wall St. Rank mantienen una posición en CAH.
- Al cierre de T3 2026, Citadel Advisors tenía 251,321 acciones de Cardinal Health con un valor de USD 55.9 M.
- Citadel Advisors compró 57,401 acciones de Cardinal Health en T3 2026, por un monto estimado de USD 13.3 M.
- Cardinal Health representó el 0.01% del portafolio de Citadel Advisors en T3 2026 y fue su posición número 1452.
- Citadel Advisors reportó por primera vez una posición en Cardinal Health en T2 2013 y desde entonces la ha mantenido en 53 trimestres.
- La posición de Citadel Advisors en Cardinal Health alcanzó su máximo de USD 493 M en T1 2026.
- Al cierre de T3 2026, 1,490 fondos que sigue Wall St. Rank tenían Cardinal Health en su portafolio.
Según el informe 13F de Citadel Advisors correspondiente a T3 2026, presentado el 16 nov 2026.